A new murine model to study the pathogenesis of tuberculous meningitis

Journal of Infectious Diseases

Volumn 195, Issue 5, 2007, Pages 694-697

  Van Well, Gijs Th J ^a,b   Wieland, Catharina W ^b   Florquin, Sandrine ^b   Roord, John J ^a   Van Der Poll, Tom ^b   Van Furth, A Marceline ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; BRAIN HOMOGENATE; C57BL 6 MOUSE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; HISTOPATHOLOGY; INNATE IMMUNITY; MONONUCLEAR PHAGOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TUBERCULOUS MENINGITIS;

ANIMALS; BRAIN; CHEMOKINES; DISEASE MODELS, ANIMAL; FEMALE; INTERFERON TYPE II; INTERLEUKINS; MICE; MICE, INBRED C57BL; TIME FACTORS; TUBERCULOSIS, MENINGEAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847067894     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/511273     Document Type: Article

References (14)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Document WHO/HTM/TB/2005.349. Geneva: World Health Organization, 2005. Available at: http://www.who.int/tb/publications/ 2005/en/index.html. Accessed 26 August 2005.
2. Farinha NJ, Razali KA, Holzel H, Morgan G, Novelli VM. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect 2000; 41:61-8.
3. Hosoglu S, Geyik MF, Balik I, et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2002; 6:64-70.
4. Rock RB, Gekker G, Hu S, et al. Role of microglia in the central nervous system. Clin Microbiol Rev 2004; 17:942-64.
5. Rich AR, McCordock HA. The pathogenesis of tuberculous meningitis. Bull Johns Hopkins Hosp 1933; 52:5-37.
6. Curto M, Reali C, Palmieri G, et al. Inhibition of cytokine expression in human microglia infected by virulent and non-virulent mycobacteria. Neurochem Int 2004; 44:381-92.
7. Rock RB, Hu S, Gekker G, et al. Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis 2005; 192:2054-8.
8. Tsenova L, Sokol K, Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis 1998; 177:1563-72.
9. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumour necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobaterial infection in the central nervous system. Proc Natl Acad Sci USA 1999; 96:5657-62.
10. Mastroianni CM, Paoletti F, Lichtner M, D'Agostino C, Vullo V, Delia S. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol 1997; 84:171-6.
11. Thwaites GE, Simmons CP, Than Ha Quyen N, et al. Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis. J Infect Dis 2003; 188:1105-15.
12. Saez-Llorens X, Ramilo O, Mustafa MM, Mertsola J, McCracken GH Jr. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr 1990; 116:671-84.
13. Mustafa MM, Lebel MH, Ramilo O, et al. Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 1989; 115:208-13.
14. Zwijnenburg PJ, van der Poll T, Roord JJ, van Furth AM. Chemotactic factors in cerebrospinal fluid during bacterial meningitis. Infect Immun 2006; 74:1445-51.